Literature DB >> 31025203

The Management of Hypertension in 2018: What Should the Targets Be?

Waleed Ali1, George Bakris2.   

Abstract

PURPOSE OF REVIEW: To provide an overview of the different guidelines for hypertension management from around the world. RECENT
FINDINGS: The guidelines discussed include those from the United States (US), Europe, Canada, and Latin America. All guidelines except the US define hypertension as > 140/90 mmHg, and the US defines it as > 130/80 mmHg. In general, all guidelines except those from the US emphasize lifestyle modification as the cornerstone of initial therapy given blood pressure levels < 140/90 mmHg. The US emphasizes lifestyle modification at all BP levels starting at 130/80 mmHg. Additionally, all guidelines emphasize the need to assess cardiovascular risk with the Canadian guidelines indicating that a high cardiovascular risk person should have a goal of < 130/80 mmHg. All agree on the proper method of blood pressure measurement techniques and importance of home blood pressure. All support use combination therapy with the European guideline emphasizing initial therapy should be a combination pill. All guidelines stress the importance of patient adherence to maintain blood pressure control. All guidelines emphasize lifestyle modification, need for home blood pressure measurement, as well as use of proper techniques to measure blood pressure. The fundamental difference between US and all other guidelines is the definition of hypertension, > 130/80 mmHg in US and > 140/90 mmHg in the rest of the world.

Entities:  

Keywords:  Guidelines; Hypertension; Mortality; Outcomes

Mesh:

Substances:

Year:  2019        PMID: 31025203     DOI: 10.1007/s11906-019-0946-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  15 in total

1.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

2.  On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.

Authors:  Yuichiro Yano; Hiromi Rakugi; George L Bakris; Donald M Lloyd-Jones; Suzanne Oparil; Takao Saruta; Kazuyuki Shimada; Hiroaki Matsuoka; Yutaka Imai; Toshio Ogihara
Journal:  Hypertension       Date:  2017-01-03       Impact factor: 10.190

3.  Guidelines on the management of arterial hypertension and related comorbidities in Latin America.

Authors: 
Journal:  J Hypertens       Date:  2017-08       Impact factor: 4.844

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

5.  Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.

Authors:  David S Wald; Malcolm Law; Joan K Morris; Jonathan P Bestwick; Nicholas J Wald
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

6.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

Review 7.  Management of hypertension in the elderly population.

Authors:  Raymond V Oliva; George L Bakris
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-08-22       Impact factor: 6.053

8.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

9.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Eva M Lonn; Jackie Bosch; Patricio López-Jaramillo; Jun Zhu; Lisheng Liu; Prem Pais; Rafael Diaz; Denis Xavier; Karen Sliwa; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Katalin Keltai; Matyas Keltai; Irina Chazova; Ron J G Peters; Claes Held; Khalid Yusoff; Basil S Lewis; Petr Jansky; Alexander Parkhomenko; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Lawrence A Leiter; Dora I Molina; Robert McKelvie; Janice Pogue; Joanne Wilkinson; Hyejung Jung; Gilles Dagenais; Salim Yusuf
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

Review 10.  Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Samir G Mallat; Bassem Y Tanios; Houssam S Itani; Tamara Lotfi; Elie A Akl
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more
  4 in total

1.  Immunoneutralization of human angiotensin-(1-12) with a monoclonal antibody in a humanized model of hypertension.

Authors:  Carlos M Ferrario; Jessica L VonCannon; Jie Zhang; Jorge P Figueroa; Kendra N Wright; Leanne Groban; Amit Saha; J Wayne Meredith; Sarfaraz Ahmad
Journal:  Peptides       Date:  2021-12-18       Impact factor: 3.750

2.  Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses.

Authors:  Panagiotis I Georgianos; Pantelis E Zebekakis; Vassilios Liakopoulos
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

3.  Study on Risk and Influencing Factors of Hypertension in Chinese Elderly.

Authors:  Shijia Song; Handong Li
Journal:  Gerontol Geriatr Med       Date:  2019-09-24

Review 4.  Risk factors of neurovascular ageing in women.

Authors:  Virginia M Miller; Muthuvel Jayachandran; Jill N Barnes; Michelle M Mielke; Kejal Kantarci; Walter A Rocca
Journal:  J Neuroendocrinol       Date:  2019-09-03       Impact factor: 3.627

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.